Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Cox

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
The Journal of Investigative Dermatology|March 7, 2001
An intrinsic antibiotic mechanism in wounds and tissue-engineered skinP Schmid, O Grenet, J Medina, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1979
Antifungal activity of tioconazole (UK-20,349), a new imidazole derivativeS Jevons, G E Gymer, K W Brammer, et al.
Psychoneuroendocrinology|March 31, 1999
Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal womenT Nickelsen, E G Lufkin, B L Riggs, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysisS W Watts, D A Cox, B G Johnson, et al.
American Heart Journal|October 1, 1989
Improved quality of life after successful balloon valvuloplasty of a stenosed mitral bioprosthesisD A Cox, P L Friedman, A P Selwyn, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 3, 2009
Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone massR W Downs, A M Moffett, A Ghosh, et al.
Protein Science : a Publication of the Protein Society|July 1, 1996
The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor bindingP R Mittl, J P Priestle, D A Cox, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1997
Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studiesL Wu, A Siddiqui, D E Morris, et al.
The American Journal of Cardiology|April 15, 1994
Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction InvestigatorsD A Cox, W J Rogers, F V Aguirre, et al.
CNS Drug Reviews|September 28, 2002
Selective estrogen receptor modulators: tissue actions and potential for CNS protectionM T Littleton-Kearney, N L Ostrowski, D A Cox, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
The Journal of Investigative Dermatology|March 7, 2001
An intrinsic antibiotic mechanism in wounds and tissue-engineered skinP Schmid, O Grenet, J Medina, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1979
Antifungal activity of tioconazole (UK-20,349), a new imidazole derivativeS Jevons, G E Gymer, K W Brammer, et al.
Psychoneuroendocrinology|March 31, 1999
Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal womenT Nickelsen, E G Lufkin, B L Riggs, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1994
Contractile serotonin-2A receptor signal transduction in guinea pig trachea: importance of protein kinase C and extracellular and intracellular calcium but not phosphoinositide hydrolysisS W Watts, D A Cox, B G Johnson, et al.
American Heart Journal|October 1, 1989
Improved quality of life after successful balloon valvuloplasty of a stenosed mitral bioprosthesisD A Cox, P L Friedman, A P Selwyn, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|October 3, 2009
Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone massR W Downs, A M Moffett, A Ghosh, et al.
Protein Science : a Publication of the Protein Society|July 1, 1996
The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor bindingP R Mittl, J P Priestle, D A Cox, et al.
Archives of Surgery (Chicago, Ill. : 1960)|July 1, 1997
Transforming growth factor beta 3 (TGF beta 3) accelerates wound healing without alteration of scar prominence. Histologic and competitive reverse-transcription-polymerase chain reaction studiesL Wu, A Siddiqui, D E Morris, et al.
The American Journal of Cardiology|April 15, 1994
Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction InvestigatorsD A Cox, W J Rogers, F V Aguirre, et al.
CNS Drug Reviews|September 28, 2002
Selective estrogen receptor modulators: tissue actions and potential for CNS protectionM T Littleton-Kearney, N L Ostrowski, D A Cox, et al.
Pageof 9